Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $253,773 - $298,706
2,620 New
2,620 $265,000
Q3 2021

Nov 08, 2021

SELL
$116.66 - $129.06 $112,110 - $124,026
-961 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $105 - $124
1 Added 0.1%
961 $111,000
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $27,210 - $32,057
250 Added 35.21%
960 $115,000
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $74,550 - $81,238
710 New
710 $78,000
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $54,984 - $66,774
-600 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $275,575 - $352,702
-3,599 Reduced 85.71%
600 $55,000
Q1 2020

May 19, 2020

BUY
$62.82 - $91.86 $263,781 - $385,720
4,199 New
4,199 $331,000
Q1 2019

Apr 30, 2019

SELL
$66.22 - $80.06 $64,233 - $77,658
-970 Closed
0 $0
Q3 2018

Nov 05, 2018

SELL
$60.81 - $73.36 $4,864 - $5,868
-80 Reduced 7.62%
970 $71,000
Q1 2018

Apr 24, 2018

BUY
$56.27 - $63.62 $11,254 - $12,724
200 Added 23.53%
1,050 $63,000
Q4 2017

Jan 29, 2018

BUY
$53.68 - $57.47 $10,736 - $11,494
200 Added 30.77%
850 $49,000
Q3 2017

Oct 30, 2017

BUY
$48.06 - $53.64 $31,239 - $34,866
650
650 $35,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Perennial Advisors, LLC Portfolio

Follow Perennial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perennial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perennial Advisors, LLC with notifications on news.